200 related articles for article (PubMed ID: 27780042)
1. Immunoexpression of BMP-2 and BMP-4 and their receptors, BMPR-IA and BMPR-II, in ameloblastomas and adenomatoid odontogenic tumors.
Nascimento MA; Nonaka CF; Barboza CA; Freitas RA; Pereira Pinto L; Souza LB
Arch Oral Biol; 2017 Jan; 73():223-229. PubMed ID: 27780042
[TBL] [Abstract][Full Text] [Related]
2. Expression of bone morphogenetic proteins and their associated molecules in ameloblastomas and adenomatoid odontogenic tumors.
Kumamoto H; Ooya K
Oral Dis; 2006 Mar; 12(2):163-70. PubMed ID: 16476038
[TBL] [Abstract][Full Text] [Related]
3. Expression of extracellular matrix proteins in ameloblastomas and adenomatoid odontogenic tumors.
de Medeiros AM; Nonaka CF; Galvão HC; de Souza LB; Freitas Rde A
Eur Arch Otorhinolaryngol; 2010 Feb; 267(2):303-10. PubMed ID: 19466441
[TBL] [Abstract][Full Text] [Related]
4. Immunoexpression of integrins in ameloblastoma, adenomatoid odontogenic tumor, and human tooth germs.
de Souza Andrade ES; Miguel MC; de Almeida Freitas R; Pereira Pinto L; Batista de Souza L
Int J Surg Pathol; 2008 Jul; 16(3):277-85. PubMed ID: 18573784
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of MDM2 protein in ameloblastomas as compared to adenomatoid odontogenic tumor.
Krishna A; Kaveri H; Naveen Kumar RK; Kumaraswamy KL; Shylaja S; Murthy S
J Cancer Res Ther; 2012; 8(2):232-7. PubMed ID: 22842367
[TBL] [Abstract][Full Text] [Related]
6. Bone morphogenetic protein-2/4 and bone morphogenetic protein receptor type IA expression in metastatic and nonmetastatic oral squamous cell carcinoma.
Soares AF; Xavier RL; da Costa Miguel MC; de Souza LB; Pinto LP
Am J Otolaryngol; 2010; 31(4):266-71. PubMed ID: 20015767
[TBL] [Abstract][Full Text] [Related]
7. Immunoexpression of bone morphogenetic protein-2 (BMP-2), BMP receptor type IA, and BMP receptor type II in metastatic and non-metastatic lower lip squamous cell carcinoma.
de Carvalho CH; Nonaka CF; de Araújo CR; de Souza LB; Pinto LP
J Oral Pathol Med; 2011 Feb; 40(2):181-6. PubMed ID: 21059107
[TBL] [Abstract][Full Text] [Related]
8. Immunoexpression of MMPs-1, -2, and -9 in ameloblastoma and odontogenic adenomatoid tumor.
Ribeiro BF; Iglesias DP; Nascimento GJ; Galvão HC; Medeiros AM; Freitas RA
Oral Dis; 2009 Oct; 15(7):472-7. PubMed ID: 19522745
[TBL] [Abstract][Full Text] [Related]
9. Expression of bone morphogenetic proteins 4 and 7 and their receptors IA, IB, and II in human ovaries from fetuses and adults.
Abir R; Ben-Haroush A; Melamed N; Felz C; Krissi H; Fisch B
Fertil Steril; 2008 May; 89(5 Suppl):1430-40. PubMed ID: 17624341
[TBL] [Abstract][Full Text] [Related]
10. Bone morphogenetic proteins.
Chen D; Zhao M; Mundy GR
Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
[TBL] [Abstract][Full Text] [Related]
11. Ameloblastoma and adenomatoid odontogenic tumor: the role of alpha2beta1, alpha3beta1, and alpha5beta1 integrins in local invasiveness and architectural characteristics.
Souza Andrade ES; da Costa Miguel MC; Pinto LP; de Souza LB
Ann Diagn Pathol; 2007 Jun; 11(3):199-205. PubMed ID: 17498594
[TBL] [Abstract][Full Text] [Related]
12. Bone morphogenetic proteins and growth and differentiation factors in the human cornea.
You L; Kruse FE; Pohl J; Völcker HE
Invest Ophthalmol Vis Sci; 1999 Feb; 40(2):296-311. PubMed ID: 9950587
[TBL] [Abstract][Full Text] [Related]
13. Hepatocyte growth factor up-regulates the expression of the bone morphogenetic protein (BMP) receptors, BMPR-IB and BMPR-II, in human prostate cancer cells.
Ye L; Lewis-Russell JM; Davies G; Sanders AJ; Kynaston H; Jiang WG
Int J Oncol; 2007 Feb; 30(2):521-9. PubMed ID: 17203235
[TBL] [Abstract][Full Text] [Related]
14. CD10 expression in stromal cells of ameloblastoma variants.
Iezzi G; Piattelli A; Rubini C; Artese L; Goteri G; Fioroni M; Carinci F
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Feb; 105(2):206-9. PubMed ID: 17942343
[TBL] [Abstract][Full Text] [Related]
15. Parenchyma-stromal interactions induce fibrosis by secreting CCN2 and promote osteoclastogenesis by stimulating RANKL and CD68 through activated TGF-β/BMP4 in ameloblastoma.
Takebe Y; Tsujigiwa H; Katase N; Siar CH; Takabatake K; Fujii M; Tamamura R; Nakano K; Nagatsuka H
J Oral Pathol Med; 2017 Jan; 46(1):67-75. PubMed ID: 27327904
[TBL] [Abstract][Full Text] [Related]
16. Expression of CD90 and P75NTR stem cell markers in ameloblastomas: a possible role in their biological behavior.
Silva FP; Dias A; Coelho CA; Guerra EN; Marques AE; Decurcio DA; Mantesso A; Cury SE; Silva BS
Braz Oral Res; 2016 Oct; 30(1):e109. PubMed ID: 27737362
[TBL] [Abstract][Full Text] [Related]
17. Adenomatoid odontogenic tumor (AOT) originating in a unicystic ameloblastoma: a case report.
Jivan V; Altini M; Meer S; Mahomed F
Head Neck Pathol; 2007 Dec; 1(2):146-9. PubMed ID: 20614266
[TBL] [Abstract][Full Text] [Related]
18. Enhanced expression of type I receptors for bone morphogenetic proteins during bone formation.
Ishidou Y; Kitajima I; Obama H; Maruyama I; Murata F; Imamura T; Yamada N; ten Dijke P; Miyazono K; Sakou T
J Bone Miner Res; 1995 Nov; 10(11):1651-9. PubMed ID: 8592941
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical detection of p53 and PCNA in ameloblastoma and adenomatoid odontogenic tumor.
Salehinejad J; Zare-Mahmoodabadi R; Saghafi S; Jafarian AH; Ghazi N; Rajaei AR; Marouzi P
J Oral Sci; 2011 Jun; 53(2):213-7. PubMed ID: 21712626
[TBL] [Abstract][Full Text] [Related]
20. Structure analysis of bone morphogenetic protein-2 type I receptor complexes reveals a mechanism of receptor inactivation in juvenile polyposis syndrome.
Kotzsch A; Nickel J; Seher A; Heinecke K; van Geersdaele L; Herrmann T; Sebald W; Mueller TD
J Biol Chem; 2008 Feb; 283(9):5876-87. PubMed ID: 18160401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
